S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

IOVA Iovance Biotherapeutics Inc

13.63

0.75 (5.82%)

After Hours

Last Updated: 06:30:00

Delayed by 15 minutes

Precipio, PDS Biotechnology leads healthcare gainers; Black Diamond Therapeutics, Aerpio Pharmaceuticals among major losers

To read the full story on Seeking Alpha, click here.

Iovance Biotherapeutics (NASDAQ:IOVA)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Iovance Biotherapeutics Charts.

Iovance Biotherapeutics (NASDAQ:IOVA)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Iovance Biotherapeutics Charts.

Iovance Biotherapeutics Inc News

Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024
Wednesday 1 May 2024 (2 days ago) • GlobeNewswire Inc.

Iovance Biotherapeutics to Present at Upcoming Conferences
Tuesday 30 April 2024 (3 days ago) • GlobeNewswire Inc.

Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual Meeting
Thursday 25 April 2024 (1 week ago) • GlobeNewswire Inc.

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Saturday 20 April 2024 (2 weeks ago) • GlobeNewswire Inc.

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Saturday 23 March 2024 (1 month ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 7 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

More Iovance Biotherapeutics Inc News Articles

Australian SE All Ordina...

JP Morgan Chase

Verizon Communications

Newcrest Mining

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions